Committee for Medicinal Products for Veterinary Use (CVMP)

The Committee for Medicinal Products for Veterinary Use (CVMP) is responsible for preparing the Agency's opinions on all questions concerning medicines for veterinary use.

It was established by Regulation (EC) No 726/2004.

• See the full overview of the CVMP's role

Composition

The members and alternates of the CVMP are nominated by the European Union Member States, in consultation with the Agency's Management Board. They are chosen on the strength of their qualifications and expertise with regard to the evaluation of medicines. They serve on the Committee for a renewable period of three years.

The CVMP is composed of:

• a chair, elected by serving CVMP members;
• one member and an alternate nominated by each of the 27 Member States;
• one member and an alternate nominated by Iceland and by Norway;
• up to five co-opted members, chosen among experts nominated by Member States or the Agency and recruited, when necessary, to provide additional expertise in a particular scientific area.

See for the list of current members

Meeting calendar

• See the full meeting plan for the CVMP